Mr K Raja Bhanu, Director General, Pharmexcil
Vizag Pharma Summit 2025 | 17th December | Fairfield by Marriott, Vizag
Speaker in this video:
Special Address: Mr K Raja Bhanu, Director General, Pharmexcil
Key Takeaways:
[1] The growth story in plain generics is clearly slowing down. For India Pharma Inc, the next phase of growth will have to come from newer, more complex areas like complex generics, biosimilars and differentiated, innovative formulations.
[2] We may be able to live with a trade deficit, but we cannot afford a trust deficit. That means raising the bar on quality, consistency and compliance, not just to meet global standards, but to set them.
[3] Equally important is building a strong, self-reliant ecosystem. We need one that strengthens local capabilities, reduces dependencies, and at the same time makes Indian pharma globally competitive.